The United States will need to have independent experts review COVID-19 vaccine candidates before approval, the country's top drug regulator said on Friday, offering reassurance that his agency would not cut corners in the race to roll out a vaccine.
FILE PHOTO: Stephen M. Hahn, commissioner of U.S. Food and Drugs Administration, speaks during a Senate Health, Education, Labor and Pensions Committee hearing on efforts to get back to work and school during the coronavirus disease outbreak, in Washington, D.C., U.S. June 30, 2020. Al Drago/Pool via REUTERS
U.S. Food and Drug Administration Commissioner Stephen Hahn said COVID-19 vaccine candidates will be reviewed according to established legal and regulatory standards for medical products, including by an outside advisory committee. The U.S. government’s Operation Warp Speed aims to expedite development of a vaccine and therapies to treat the novel coronavirus, and the emphasis on speed has provoked public anxiety about the safety and effectiveness of these vaccines, Hahn and the other officials wrote.
Earlier this week, the country’s infectious diseases chief, Anthony Fauci, told Reuters political pressure will not determine when a coronavirus vaccine is approved. At about the same time, U.S. President Donald Trump said it was possible for the country to have a coronavirus vaccine before the Nov. 3 election.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Coronavirus tally: Gobal cases of COVID-19 top 19 million and U.S. death toll tops 160,000The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 19 million on Friday, according to data aggregated by Johns...
Weiterlesen »
Russia offers to supply Philippines with COVID-19 vaccineRussia is willing to supply a coronavirus vaccine to the Philippines, or team up with a local firm to mass produce it, its ambassador to Manila said on Friday, as infections in the Southeast Asian nation surge.
Weiterlesen »
Fauci warns COVID-19 vaccine may be only partially effective, public health measures still neededAn approved coronavirus vaccine could end up being effective only 50-60% of the time, meaning public health measures will still be needed to keep the pandemic under control, Dr. Anthony Fauci, the top U.S. infectious diseases expert, said on Friday.
Weiterlesen »
AstraZeneca Strikes Deal to Produce Covid-19 Vaccine for ChinaAstraZeneca has agreed to have a Chinese drugmaker produce hundreds of millions of doses of its experimental Covid-19 vaccine for use in China if it is approved by regulators there, a deal that expands China’s access to potential vaccine options.
Weiterlesen »
Novavax signs COVID-19 vaccine supply deal with India's Serum InstituteNovavax Inc said on Wednesday it has entered a supply and license agreement with the Serum Institute of India for the development and commercialization of its COVID-19 vaccine candidate.
Weiterlesen »